Cartalax 20mg

Cartalax (Ala-Glu-Asp) is a synthetic tripeptide bioregulator from the Khavinson peptide-bioregulator research program, studied for its proposed role in cartilage and connective-tissue gene-expression regulation. Its published evidence base is comparatively early-stage, with the proposed epigenetic mechanism not yet independently replicated at scale — it is best understood as a research tool for studying short-peptide bioregulator activity rather than a validated therapeutic candidate.

Research Applications

• Short-peptide bioregulator and epigenetic-modulation research
• Chondrocyte gene-expression signaling studies
• Connective-tissue regulatory-peptide research models
• Comparative research against other Khavinson-program bioregulator peptides

Specifications

Synthetic tripeptide (Ala-Glu-Asp) · Lyophilized powder · 99.91% purity (HPLC-UV/LC-MS, Certificate of Analysis on file, Lot: AXCART20-072726-001)

Certificate of Analysis: Download COA (PDF)

This product is intended strictly for laboratory research use only and is not for human or animal consumption. See our full Research Use Disclaimer.